Pharmaceuticals News and Research

RSS

Bayer's takeover offer for Schering AG complete

Bayer's public takeover offer for Schering AG has been completed. Following expiration of the additional acceptance period, Bayer now has control of 92.4 percent of the approximately 191 million outstanding Schering shares.

13 Jul 2006

FDA approves Atripla three-drug combination tablet for treatment of HIV-1

FDA approves Atripla Tablets, a fixed-dose combination of three widely-used antiretroviral drugs.

12 Jul 2006

3D model reveals secrets of metastasis

A cancer cell breaks away from a primary tumor and settles in a new location, where it once again divides.

12 Jul 2006

University of Florida and France sign cooperative four-year research agreement

The University of Florida and two biomedical institutes in France have signed a four-year cooperative agreement on biopharmaceutical research that is designed to help bring new therapies to clinical trials.

11 Jul 2006

Fombonne's autism research is dangerously inaccurate

Fombonne, a thimerosal litigation expert witness on behalf of various pharmaceutical companies, will reportedly state that it is "very clear" there is no relationship between mercury-based thimerosal and the onset of autism.

11 Jul 2006

SRU Biosystems awarded new U.S. patent

SRU Biosystems has announced that U.S. Patent 7,070,987 (the '987 patent), entitled "Guided mode resonant filter biosensor using a linear grating surface structure" was issued to SRU Biosystems, Inc. on July 4, 2006.

10 Jul 2006

Cardinal Health to manufacture Tamiflu for Roche

Cardinal Health, the leading provider of products and services supporting the health-care industry, has announced that it has signed agreements to manufacture and package Tamiflu for Roche to help meet current and future demand for the influenza medicine.

10 Jul 2006

Which inflammatory markers predict the appearance of a stroke?

Patients that have suffered from a stroke have a higher risk of a similar event happening and, in consequence, greater possibilities of dying.

10 Jul 2006

Two-thirds of patients say Uprima didn't work for them

Two-thirds of patients stopped using Uprima, a drug commonly prescribed for erection problems, because they felt it wasn't effective, according to a large-scale study published in the July issue of the urology journal BJU International.

10 Jul 2006

Media coverage of obesity outweighs smoking cessation stories

Obesity is grabbing more headlines, but not necessarily crowding out media coverage of the dangers of tobacco use, according to a new study sponsored by a drug company. However obesity made more news while tobacco got less attention, based on an analysis of eight years of medical stories in the media.

5 Jul 2006

Just how safe is that steak?

A government adviser in the UK has refused to put his name to a report which says the hormones used in cattle are safe for human consumption.

4 Jul 2006

New polymer-lipid hybrid nanoparticle

A novel combination of lipids, a negatively charged polymer, and the anticancer drug doxorubicin has yielded a new nanoparticle that can kill breast cancer cells that are normally resistant to this drug.

3 Jul 2006

New gene amplification findings could benefit cancer research

Gene amplification plays an important role in causing cancers via activation of oncogenes.

29 Jun 2006

Aussies trial promising bird flu vaccine

An Australian vaccine against the deadly bird flu has shown such good results in preliminary trials that researchers are about to test it on volunteers.

29 Jun 2006

Brits first to get new obesity drug

The drug Acomplia is a new weight loss preparation that curbs the desire to over-eat and British patients will be the first worldwide to access the medication.

28 Jun 2006

Drug trial horror gave victim '4 months of hell'

One of the six volunteers who were left critically ill when a drug trial went horribly wrong has spoken out about his ordeal.

28 Jun 2006

Vaccine no replacement for Pap test

The Cancer Council Australia cautioned that the vaccine was not a substitute for the Pap screen and that all women aged 18-69 should continue regular two year screening.

27 Jun 2006

First-in-class biologics poised to drive malignant melanoma drug market

Decision Resources, Inc., a research and advisory firm focusing on pharmaceutical and healthcare issues, finds that first-in-class targeted biologics will enter the malignant melanoma market during the next five years.

27 Jun 2006

FDA approves Exelon to treat dementia of Parkinson's disease

FDA approves Exelon (rivastigmine tartrate) for the treatment of mild to moderate dementia associated with Parkinson's disease.

27 Jun 2006

Affymax and Takeda announce agreement for commercialization of Hematide for anemia

Affymax and Takeda Pharmaceutical Company have announced that the companies have entered into an exclusive global agreement to develop and commercialize Affymax's lead product candidate, Hematide, for the treatment of anemia.

27 Jun 2006